You are here: Home » Current Affairs » Coronavirus » News
Business Standard

India may allow smaller gap between Covishield doses sold privately: Report

Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine 4 weeks after the first, down from between 12 and 16 weeks currently, say sources

Coronavirus | AstraZeneca | Coronavirus Vaccine


India too had opened diplomatic dialogues with the European Union (EU) after the EU Digital Covid Certificate framework recognised the AstraZeneca-Oxford vaccine, but not Covishield.

India is likely to allow a smaller gap between COVID-19 vaccine doses for inoculations being carried out privately, in line with a court order, two sources told Reuters.

Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and 16 weeks currently, they said.

Earlier this month, the high court in the southern state of Kerala ordered changes in the health ministry's vaccine-booking platform to give people paying for vaccination this choice, which is already being offered to those flying abroad. read more

"Since the high court has given a judgement, it will have to be done," said one of the sources. "For the government's programme, the ideal gap remains 12 weeks."

India doubled the gap between the vaccine's two doses in May to make sure more people were inoculated with at least one dose when supplies were scarce at the height of the country's outbreak this year.

recommends the second dose of its COVID-19 vaccine be taken four weeks after the first shot, but says on its website there is a "trend of increased efficacy with a longer than 4 week dosing interval". The World Health Organization recommends an interval of eight to 12 weeks.

The sources, who declined to be named because they were not authorised to speak to the media, could not say when the changes will be implemented.

The health ministry did not immediately respond to a request for comment.

India's total vaccine output has trebled since May to 300 million doses a month. Less than a quarter of the production is sold by private hospitals while the rest is provided by the government free of cost.

India has administered at least one dose of the COVID-19 vaccine in 65% of its 944 million adults and two doses in 22% of adults.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, September 22 2021. 14:14 IST